<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20241225214156&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20241225214156&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;fc=20230708114047&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Thu, 26 Dec 2024 02:41:56 +0000</lastbuilddate>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Takotsubo syndrome during percutaneous coronary intervention: the role of myocardial ischaemia and microvascular dysfunction in pathophysiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39718258/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 24:ehae902. doi: 10.1093/eurheartj/ehae902. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39718258/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39718258</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae902>10.1093/eurheartj/ehae902</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39718258</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Taiji Okada</dc:creator>
<dc:creator>Osamu Kurihara</dc:creator>
<dc:creator>Masamichi Takano</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Takotsubo syndrome during percutaneous coronary intervention: the role of myocardial ischaemia and microvascular dysfunction in pathophysiology</dc:title>
<dc:identifier>pmid:39718258</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae902</dc:identifier>
</item>
<item>
<title>Left ventriculo-atrial fistula following catheter ablation for Wolff-Parkinson-White syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39718255/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 24:ehae901. doi: 10.1093/eurheartj/ehae901. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39718255/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39718255</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae901>10.1093/eurheartj/ehae901</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39718255</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Zhen-Gang Zhao</dc:creator>
<dc:creator>Fei Chen</dc:creator>
<dc:creator>Yuan Feng</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Left ventriculo-atrial fistula following catheter ablation for Wolff-Parkinson-White syndrome</dc:title>
<dc:identifier>pmid:39718255</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae901</dc:identifier>
</item>
<item>
<title>Arterial conduits for coronary bypass grafting: the set-point concept</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39718243/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>Endothelial cells control the vascular tone of arterial grafts used for coronary artery bypass surgery and react to changes in local shear stress. The vascular adaptations induced by endothelial cell activation affect the outcome of surgical grafts and can be predicted based on the set-point theory. In this Hypothesis piece, it is proposed that the set-point concept should inform surgical decision making for coronary artery bypass surgery.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 24:ehae908. doi: 10.1093/eurheartj/ehae908. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Endothelial cells control the vascular tone of arterial grafts used for coronary artery bypass surgery and react to changes in local shear stress. The vascular adaptations induced by endothelial cell activation affect the outcome of surgical grafts and can be predicted based on the set-point theory. In this Hypothesis piece, it is proposed that the set-point concept should inform surgical decision making for coronary artery bypass surgery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39718243/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39718243</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae908>10.1093/eurheartj/ehae908</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39718243</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Antonio M Calafiore</dc:creator>
<dc:creator>Sotirios Prapas</dc:creator>
<dc:creator>Mario Gaudino</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Arterial conduits for coronary bypass grafting: the set-point concept</dc:title>
<dc:identifier>pmid:39718243</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae908</dc:identifier>
</item>
<item>
<title>Collagen Pyridinoline Cross-Links Are Absent in Reversible Myocardial Fibrosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39717913/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2024 Dec 24. doi: 10.1161/CIRCRESAHA.124.325406. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39717913/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39717913</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325406>10.1161/CIRCRESAHA.124.325406</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39717913</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Eman Akam-Baxter</dc:creator>
<dc:creator>Sterling J Ridley</dc:creator>
<dc:creator>Brianna F Moon</dc:creator>
<dc:creator>Peter Caravan</dc:creator>
<dc:creator>David E Sosnovik</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Collagen Pyridinoline Cross-Links Are Absent in Reversible Myocardial Fibrosis</dc:title>
<dc:identifier>pmid:39717913</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325406</dc:identifier>
</item>
<item>
<title>Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39716283/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>Atrial fibrillation (AF) has become the pre-dominant arrhythmia worldwide and is associated with high morbidity and mortality. Its pathogenesis is intricately linked to the deleterious impact of cardiovascular risk factors, emphasizing the pivotal imperative for early detection and mitigation strategies targeting these factors for the prevention of primary AF. While traditional risk factors are well recognized, an increasing number of novel risk factors have been identified in recent decades....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 24:ehae887. doi: 10.1093/eurheartj/ehae887. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Atrial fibrillation (AF) has become the pre-dominant arrhythmia worldwide and is associated with high morbidity and mortality. Its pathogenesis is intricately linked to the deleterious impact of cardiovascular risk factors, emphasizing the pivotal imperative for early detection and mitigation strategies targeting these factors for the prevention of primary AF. While traditional risk factors are well recognized, an increasing number of novel risk factors have been identified in recent decades. This review explores the emerging non-traditional risk factors for the primary prevention of AF, including unhealthy lifestyle factors in current society (sleep, night shift work, and diet), biomarkers (gut microbiota, hyperuricaemia, and homocysteine), adverse conditions or diseases (depression, epilepsy, clonal haematopoiesis of indeterminate potential, infections, and asthma), and environmental factors (acoustic pollution and other environmental factors). Unlike traditional risk factors, individuals have limited control over many of these non-traditional risk factors, posing challenges to conventional prevention strategies. The purpose of this review is to outline the current evidence on the associations of non-traditional risk factors with new-onset AF and the potential mechanisms related to these risk factors. Furthermore, this review aims to explore potential interventions targeting these risk factors at both the individual and societal levels to mitigate the growing burden of AF, suggesting guideline updates for primary AF prevention.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39716283/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39716283</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae887>10.1093/eurheartj/ehae887</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39716283</guid>
<pubDate>Tue, 24 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Yingli Lu</dc:creator>
<dc:creator>Ying Sun</dc:creator>
<dc:creator>Lingli Cai</dc:creator>
<dc:creator>Bowei Yu</dc:creator>
<dc:creator>Yuying Wang</dc:creator>
<dc:creator>Xiao Tan</dc:creator>
<dc:creator>Heng Wan</dc:creator>
<dc:creator>Dachun Xu</dc:creator>
<dc:creator>Junfeng Zhang</dc:creator>
<dc:creator>Lu Qi</dc:creator>
<dc:creator>Prashanthan Sanders</dc:creator>
<dc:creator>Ningjian Wang</dc:creator>
<dc:date>2024-12-24</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies</dc:title>
<dc:identifier>pmid:39716283</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae887</dc:identifier>
</item>
<item>
<title>Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A Review</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714903/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: Although commercially available in numerous countries now for more than a decade, DCB only recently obtained US Food and Drug Administration approval for the treatment of coronary ISR. Moreover, preliminary results from newer generation devices tested in different clinical scenarios have raised the interest of the international community. Accordingly, an up-to-date review is timely particularly with the anticipated wave of research on the matter. Herein, this review...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Dec 23. doi: 10.1001/jamacardio.2024.4244. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Drug-coated balloon (DCB) angioplasty has emerged as an alternative to drug-eluting stent (DES) implantation for percutaneous coronary intervention (PCI) in patients with coronary in-stent restenosis (ISR) as well as de novo coronary artery disease.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBSERVATIONS: DCBs are balloons coated with antiproliferative agents and excipients, whose aim is to foster favorable vessel healing after appropriate lesion preparation. By providing homogeneous antiproliferative drug delivery in the absence of permanent foreign body implantation, DCBs offer multiple advantages over DES, including preservation of vessel anatomy and function and positive vessel remodeling. As such, DCBs have become appealing for treatment of ISR, small-vessel disease, long lesions, simplification of bifurcation procedures, and treatment of diffuse distal disease after recanalization of chronic total occlusions. In addition, patients with high bleeding risk, diabetes, and acute coronary syndrome might also stand to benefit from DCB angioplasty.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: Although commercially available in numerous countries now for more than a decade, DCB only recently obtained US Food and Drug Administration approval for the treatment of coronary ISR. Moreover, preliminary results from newer generation devices tested in different clinical scenarios have raised the interest of the international community. Accordingly, an up-to-date review is timely particularly with the anticipated wave of research on the matter. Herein, this review encompasses DCB technologies, their worldwide usage, details on relevant indications, and key procedural aspects of DCB angioplasty.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714903/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39714903</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.4244>10.1001/jamacardio.2024.4244</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714903</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Anton Camaj</dc:creator>
<dc:creator>Pier Pasquale Leone</dc:creator>
<dc:creator>Antonio Colombo</dc:creator>
<dc:creator>Manish Vinayak</dc:creator>
<dc:creator>Gregg W Stone</dc:creator>
<dc:creator>Roxana Mehran</dc:creator>
<dc:creator>George Dangas</dc:creator>
<dc:creator>Annapoorna Kini</dc:creator>
<dc:creator>Samin K Sharma</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A Review</dc:title>
<dc:identifier>pmid:39714903</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.4244</dc:identifier>
</item>
<item>
<title>Intravascular Sympathetic Stimulation to Facilitate Catheter Ablation of Premature Ventricular Complexes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714902/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: These findings suggest that intravascular sympathetic stimulation via the VV can be used to safely provoke PVCs during catheter ablation.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Dec 23. doi: 10.1001/jamacardio.2024.4447. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Infrequent intraprocedural premature ventricular complexes (PVCs) limit the efficacy of catheter ablation. Intravascular stimulation of sympathetic nerves via vertebral veins (VVs) has been used to activate cardiac sympathetic tone and may promote PVCs.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To characterize the ability of direct electrical sympathetic stimulation via VVs to induce PVCs at the time of catheter ablation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This prospective case series involved adult patients undergoing catheter ablation of PVCs, with rare or absent PVCs despite standard provocation, at the Hospital of the University of Pennsylvania between 2022 and 2024. Stimulation was performed via the left VV (20 Hz, up to 25 mA).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The primary outcome was PVC frequency, assessed before, during, and after stimulation. A multilevel mixed-effects Poisson regression was used to compare the rate of PVCs during the procedure.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Fifteen patients (mean [SD] age, 60 [17] years; 10 male [71%]) had a mean (SD) preprocedure PVC burden of 16.3% (8.6%) (median [IQR], 17.0% [11.5%-21.5%]), and 7 of 15 had undergone at least 1 prior unsuccessful ablation. Provocation of PVCs was attempted with isoproterenol, atrial and ventricular burst pacing, and minimal sedation in all patients before VV stimulation. Throughout the 10-minute period before VV stimulation, patients had a mean (SD) of 1.3 (1.4) PVCs (median [IQR], 1.0 [0.0-2.5] PVCs). During VV stimulation, PVCs were noted in all patients (mean [SD], 8.2 [5.7] PVCs per minute; median [IQR], 6.0 [4.5-13.0] PVCs per minute). In the 10-minute period after VV stimulation, patients had a mean (SD) of 5.1 (6.6) PVCs per minute (median [IQR], 3.0 [0.5-6.5] PVCs per minute). After VV stimulation, ablation was guided by activation mapping in 7 patients and by pace mapping alone in the remaining patients. Postablation monitoring demonstrated a mean (SD) 1.3% (2.3%) burden of PVCs (median [IQR], 0.0% [0.0%-2.5%]), with 9 of 15 patients having less than 1% burden of PVCs. There were no adverse events related to VV stimulation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: These findings suggest that intravascular sympathetic stimulation via the VV can be used to safely provoke PVCs during catheter ablation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714902/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39714902</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.4447>10.1001/jamacardio.2024.4447</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714902</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Timothy M Markman</dc:creator>
<dc:creator>Cory M Tschabrunn</dc:creator>
<dc:creator>David Callans</dc:creator>
<dc:creator>Francis E Marchlinski</dc:creator>
<dc:creator>Saman Nazarian</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Intravascular Sympathetic Stimulation to Facilitate Catheter Ablation of Premature Ventricular Complexes</dc:title>
<dc:identifier>pmid:39714902</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.4447</dc:identifier>
</item>
<item>
<title>Representation of Women Among Cardiology Grand Rounds Speakers in the United States</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714874/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: Women compose about 1 in 5 cardiology GR speakers with modest growth in representation over time but remain underrepresented as GR speakers for procedural cardiology and basic/translational science topics.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Dec 23. doi: 10.1001/jamacardio.2024.4255. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Women are underrepresented in leadership positions in cardiology. Institutional grand rounds (GR) are platforms through which faculty can gain professional exposure and access to career development opportunities. The gender diversity of invited cardiology GR speakers has not been investigated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To examine the representation of women among cardiology GR speakers in the United States.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study reviewed all 626 internal medicine residency training program websites in the American Medical Association's FRIEDA directory to identify publicly available records of cardiology GR. Grand rounds from September 1997 through December 2022 were included; GR with more than 1 speaker and trainee-led case conferences were excluded.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURES: Grand rounds speaker gender.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Data on GR topic focus, speaker gender, and academic rank were collected.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 3806 GR lectures at 42 institutions were included; 799 (21%) were delivered by women and 3007 (79%) by men. The proportion of women GR speakers increased by 1% per year and increased for each topic over time with the exception of electrophysiology and basic/translational science. Women were most likely to speak on women's cardiovascular health (80 lectures [10.0%] vs 17 [0.6%] for men; P &lt; .001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: Women compose about 1 in 5 cardiology GR speakers with modest growth in representation over time but remain underrepresented as GR speakers for procedural cardiology and basic/translational science topics.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714874/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39714874</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.4255>10.1001/jamacardio.2024.4255</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714874</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Ersilia M DeFilippis</dc:creator>
<dc:creator>Supriya Muppala</dc:creator>
<dc:creator>Gurleen Kaur</dc:creator>
<dc:creator>Jessica H Huston</dc:creator>
<dc:creator>Robert A Harrington</dc:creator>
<dc:creator>Quinn Capers</dc:creator>
<dc:creator>Pamela S Douglas</dc:creator>
<dc:creator>Nadim Mahmud</dc:creator>
<dc:creator>Nosheen Reza</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Representation of Women Among Cardiology Grand Rounds Speakers in the United States</dc:title>
<dc:identifier>pmid:39714874</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.4255</dc:identifier>
</item>
<item>
<title>Plugging the gap: vascular access closure after transfemoral transcatheter aortic valve implantation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714781/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23:ehae876. doi: 10.1093/eurheartj/ehae876. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714781/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39714781</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae876>10.1093/eurheartj/ehae876</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714781</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Daniel T Y Ang</dc:creator>
<dc:creator>M Mitchell Lindsay</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Plugging the gap: vascular access closure after transfemoral transcatheter aortic valve implantation</dc:title>
<dc:identifier>pmid:39714781</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae876</dc:identifier>
</item>
<item>
<title>The hypothesis: a new article type and platform for iconoclasts in medicine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714777/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23:ehae770. doi: 10.1093/eurheartj/ehae770. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714777/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39714777</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae770>10.1093/eurheartj/ehae770</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714777</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Milton Packer</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The hypothesis: a new article type and platform for iconoclasts in medicine</dc:title>
<dc:identifier>pmid:39714777</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae770</dc:identifier>
</item>
<item>
<title>Whether women undergoing assisted reproductive technologies have an increased risk of cardiovascular disease remains an unanswered question</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39714774/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23:ehae910. doi: 10.1093/eurheartj/ehae910. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39714774/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39714774</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae910>10.1093/eurheartj/ehae910</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39714774</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Maria Christine Magnus</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Whether women undergoing assisted reproductive technologies have an increased risk of cardiovascular disease remains an unanswered question</dc:title>
<dc:identifier>pmid:39714774</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae910</dc:identifier>
</item>
<item>
<title>Cardiovascular safety of assisted reproductive technology: a meta-analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39710934/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Assisted reproductive technology use does not appear to be significantly associated with an increased long-term risk of cardiovascular diseases in women. While these findings suggest the cardiovascular safety of fertility treatments, further research is warranted.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23:ehae886. doi: 10.1093/eurheartj/ehae886. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: The increasing use of assisted reproductive technology (ART) has raised concerns regarding its long-term cardiovascular safety due to potential hormonal imbalances and pro-thrombotic states. This study aimed to assess the long-term cardiovascular risk associated with fertility treatments in women.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Following PRISMA guidelines, a systematic review and meta-analysis was conducted in MEDLINE (via PubMed) from inception to January 2024. Randomized, cohort, or case-control studies were included if fulfilling the following criteria: the association between ART and the subsequent cardiovascular outcome was reported and adjusted for confounding factors (at least age); the presence of a control group; and minimum 1-year follow-up. Effect size (ES) estimates of the association between fertility therapy and subsequent cardiovascular disease were pooled using the DerSimonian and Laird random-effects model. Heterogeneity was assessed with the I2 index. This study is registered on PROSPERO (CRD42024505605).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of the 7298 articles screened, 10 studies were included, encompassing 500 664 women undergoing ART and 36 395 240 controls. The analysis found no significant increase in the long-term risk of major adverse cardiovascular events [ES 1.04, 95% confidence interval (CI) 0.88-1.23, I2 87.61%, P = .63], coronary heart disease (ES 0.88, 95% CI 0.71-1.10, I2 24.36%, P = .26), stroke (ES 1.21, 95% CI 0.92-1.59, I2 70.40%, P = .17), venous thromboembolism (ES 0.95, 95% CI 0.70-1.28, I2 49.13%, P = .73), hypertension (ES 1.08, 95% CI 0.88-1.32, I2 94.63%, P = .46), or diabetes (ES 1.03, 95% CI 0.86-1.22, I2 78.44%, P = .77). Assisted reproductive technology was associated with a lower risk of heart failure (ES 0.75, 95% CI 0.60-0.94, I2 0.00%, P = .01).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Assisted reproductive technology use does not appear to be significantly associated with an increased long-term risk of cardiovascular diseases in women. While these findings suggest the cardiovascular safety of fertility treatments, further research is warranted.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39710934/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39710934</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae886>10.1093/eurheartj/ehae886</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39710934</guid>
<pubDate>Mon, 23 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Carlo Andrea Pivato</dc:creator>
<dc:creator>Annalisa Inversetti</dc:creator>
<dc:creator>Gianluigi Condorelli</dc:creator>
<dc:creator>Alaide Chieffo</dc:creator>
<dc:creator>Paolo Emanuele Levi-Setti</dc:creator>
<dc:creator>Alessia Chiara Latini</dc:creator>
<dc:creator>Andrea Busnelli</dc:creator>
<dc:creator>Martina Messa</dc:creator>
<dc:creator>Martina Cristodoro</dc:creator>
<dc:creator>Renato Maria Bragato</dc:creator>
<dc:creator>Marco Francone</dc:creator>
<dc:creator>Luisa Zuccolo</dc:creator>
<dc:creator>Francesca Ieva</dc:creator>
<dc:creator>Emanuele Di Angelantonio</dc:creator>
<dc:creator>Giulio Stefanini</dc:creator>
<dc:creator>Nicoletta Di Simone</dc:creator>
<dc:date>2024-12-23</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardiovascular safety of assisted reproductive technology: a meta-analysis</dc:title>
<dc:identifier>pmid:39710934</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae886</dc:identifier>
</item>
<item>
<title>Sex-specific risk factors: new light shed on gestational diabetes and obesity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39709997/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 23;45(48):5105-5108. doi: 10.1093/eurheartj/ehae837.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39709997/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39709997</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae837>10.1093/eurheartj/ehae837</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39709997</guid>
<pubDate>Sun, 22 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-12-22</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Sex-specific risk factors: new light shed on gestational diabetes and obesity</dc:title>
<dc:identifier>pmid:39709997</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae837</dc:identifier>
</item>
<item>
<title>Periodic ER-plasma membrane junctions support long-range Ca&lt;sup>;2+&lt;/sup>; signal integration in dendrites</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39708809/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>Neuronal dendrites must relay synaptic inputs over long distances, but the mechanisms by which activity-evoked intracellular signals propagate over macroscopic distances remain unclear. Here, we discovered a system of periodically arranged endoplasmic reticulum-plasma membrane (ER-PM) junctions tiling the plasma membrane of dendrites at ∼1 μm intervals, interlinked by a meshwork of ER tubules patterned in a ladder-like array. Populated with Junctophilin-linked plasma membrane voltage-gated...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 18:S0092-8674(24)01345-X. doi: 10.1016/j.cell.2024.11.029. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Neuronal dendrites must relay synaptic inputs over long distances, but the mechanisms by which activity-evoked intracellular signals propagate over macroscopic distances remain unclear. Here, we discovered a system of periodically arranged endoplasmic reticulum-plasma membrane (ER-PM) junctions tiling the plasma membrane of dendrites at ∼1 μm intervals, interlinked by a meshwork of ER tubules patterned in a ladder-like array. Populated with Junctophilin-linked plasma membrane voltage-gated Ca<sup>2+</sup> channels and ER Ca<sup>2+</sup>-release channels (ryanodine receptors), ER-PM junctions are hubs for ER-PM crosstalk, fine-tuning of Ca<sup>2+</sup> homeostasis, and local activation of the Ca<sup>2+</sup>/calmodulin-dependent protein kinase II. Local spine stimulation activates the Ca<sup>2+</sup> modulatory machinery, facilitating signal transmission and ryanodine-receptor-dependent Ca<sup>2+</sup> release at ER-PM junctions over 20 μm away. Thus, interconnected ER-PM junctions support signal propagation and Ca<sup>2+</sup> release from the spine-adjacent ER. The capacity of this subcellular architecture to modify both local and distant membrane-proximal biochemistry potentially contributes to dendritic computations.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39708809/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39708809</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.029>10.1016/j.cell.2024.11.029</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39708809</guid>
<pubDate>Sat, 21 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Lorena Benedetti</dc:creator>
<dc:creator>Ruolin Fan</dc:creator>
<dc:creator>Aubrey V Weigel</dc:creator>
<dc:creator>Andrew S Moore</dc:creator>
<dc:creator>Patrick R Houlihan</dc:creator>
<dc:creator>Mark Kittisopikul</dc:creator>
<dc:creator>Grace Park</dc:creator>
<dc:creator>Alyson Petruncio</dc:creator>
<dc:creator>Philip M Hubbard</dc:creator>
<dc:creator>Song Pang</dc:creator>
<dc:creator>C Shan Xu</dc:creator>
<dc:creator>Harald F Hess</dc:creator>
<dc:creator>Stephan Saalfeld</dc:creator>
<dc:creator>Vidhya Rangaraju</dc:creator>
<dc:creator>David E Clapham</dc:creator>
<dc:creator>Pietro De Camilli</dc:creator>
<dc:creator>Timothy A Ryan</dc:creator>
<dc:creator>Jennifer Lippincott-Schwartz</dc:creator>
<dc:date>2024-12-21</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Periodic ER-plasma membrane junctions support long-range Ca&lt;sup>;2+&lt;/sup>; signal integration in dendrites</dc:title>
<dc:identifier>pmid:39708809</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.029</dc:identifier>
</item>
<item>
<title>Structural determinants of co-translational protein complex assembly</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39708808/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>Protein assembly into functional complexes is critical to life's processes. While complex assembly is classically described as occurring between fully synthesized proteins, recent work showed that co-translational assembly is prevalent in human cells. However, the biological basis for the existence of this process and the identity of protein pairs that assemble co-translationally remain unknown. We show that co-translational assembly is governed by structural characteristics of complexes and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 18:S0092-8674(24)01330-8. doi: 10.1016/j.cell.2024.11.013. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Protein assembly into functional complexes is critical to life's processes. While complex assembly is classically described as occurring between fully synthesized proteins, recent work showed that co-translational assembly is prevalent in human cells. However, the biological basis for the existence of this process and the identity of protein pairs that assemble co-translationally remain unknown. We show that co-translational assembly is governed by structural characteristics of complexes and involves mutually stabilized subunits. Accordingly, co-translationally assembling subunits are unstable in isolation and exhibit synchronized proteostasis with their partner. By leveraging structural signatures and AlphaFold2-based predictions, we accurately predicted co-translational assembly, including pair identities, at proteome scale and across species. We validated our predictions by ribosome profiling, stoichiometry perturbations, and single-molecule RNA-fluorescence in situ hybridization (smFISH) experiments that revealed co-localized mRNAs. This work establishes a fundamental connection between protein structure and the translation process, highlighting the overarching impact of three-dimensional structure on gene expression, mRNA localization, and proteostasis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39708808/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39708808</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.013>10.1016/j.cell.2024.11.013</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39708808</guid>
<pubDate>Sat, 21 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Saurav Mallik</dc:creator>
<dc:creator>Johannes Venezian</dc:creator>
<dc:creator>Arseniy Lobov</dc:creator>
<dc:creator>Meta Heidenreich</dc:creator>
<dc:creator>Hector Garcia-Seisdedos</dc:creator>
<dc:creator>Todd O Yeates</dc:creator>
<dc:creator>Ayala Shiber</dc:creator>
<dc:creator>Emmanuel D Levy</dc:creator>
<dc:date>2024-12-21</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Structural determinants of co-translational protein complex assembly</dc:title>
<dc:identifier>pmid:39708808</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.013</dc:identifier>
</item>
<item>
<title>Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39708807/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>Sustained lymphocyte migration from blood into lymph nodes (LNs) is important for immune responses. The CC-chemokine receptor-7 (CCR7) ligand CCL21 is required for LN entry but is downregulated during inflammation, and it has been unclear how recruitment is maintained. Here, we show that the oxysterol biosynthetic enzyme cholesterol-25-hydroxylase (Ch25h) is upregulated in LN high endothelial venules during viral infection. Lymphocytes become dependent on oxysterols, generated through a...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 17:S0092-8674(24)01347-3. doi: 10.1016/j.cell.2024.11.031. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Sustained lymphocyte migration from blood into lymph nodes (LNs) is important for immune responses. The CC-chemokine receptor-7 (CCR7) ligand CCL21 is required for LN entry but is downregulated during inflammation, and it has been unclear how recruitment is maintained. Here, we show that the oxysterol biosynthetic enzyme cholesterol-25-hydroxylase (Ch25h) is upregulated in LN high endothelial venules during viral infection. Lymphocytes become dependent on oxysterols, generated through a transcellular endothelial-fibroblast metabolic pathway, and the receptor EBI2 for inflamed LN entry. Additionally, Langerhans cells are an oxysterol source. Ch25h is also expressed in inflamed peripheral endothelium, and EBI2 mediates B cell recruitment in a tumor model. Finally, we demonstrate that LN CCL19 is critical in lymphocyte recruitment during inflammation. Thus, our work explains how naive precursor trafficking is sustained in responding LNs, identifies a role for oxysterols in cell recruitment into inflamed tissues, and establishes a logic for the CCR7 two-ligand system.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39708807/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39708807</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.031>10.1016/j.cell.2024.11.031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39708807</guid>
<pubDate>Sat, 21 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Kevin Y Chen</dc:creator>
<dc:creator>Marco De Giovanni</dc:creator>
<dc:creator>Ying Xu</dc:creator>
<dc:creator>Jinping An</dc:creator>
<dc:creator>Nikhita Kirthivasan</dc:creator>
<dc:creator>Erick Lu</dc:creator>
<dc:creator>Kan Jiang</dc:creator>
<dc:creator>Stephen Brooks</dc:creator>
<dc:creator>Serena Ranucci</dc:creator>
<dc:creator>Jiuling Yang</dc:creator>
<dc:creator>Shuto Kanameishi</dc:creator>
<dc:creator>Kenji Kabashima</dc:creator>
<dc:creator>Kevin Brulois</dc:creator>
<dc:creator>Michael Bscheider</dc:creator>
<dc:creator>Eugene C Butcher</dc:creator>
<dc:creator>Jason G Cyster</dc:creator>
<dc:date>2024-12-21</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes</dc:title>
<dc:identifier>pmid:39708807</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.031</dc:identifier>
</item>
<item>
<title>A gut commensal protozoan determines respiratory disease outcomes by shaping pulmonary immunity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39706191/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>The underlying mechanisms used by the intestinal microbiota to shape disease outcomes of the host are poorly understood. Here, we show that the gut commensal protozoan, Tritrichomonas musculis (T.mu), remotely shapes the lung immune landscape to facilitate perivascular shielding of the airways by eosinophils. Lung-specific eosinophilia requires a tripartite immune network between gut-derived inflammatory group 2 innate lymphoid cells and lung-resident T cells and B cells. This network...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 12:S0092-8674(24)01336-9. doi: 10.1016/j.cell.2024.11.020. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The underlying mechanisms used by the intestinal microbiota to shape disease outcomes of the host are poorly understood. Here, we show that the gut commensal protozoan, Tritrichomonas musculis (T.mu), remotely shapes the lung immune landscape to facilitate perivascular shielding of the airways by eosinophils. Lung-specific eosinophilia requires a tripartite immune network between gut-derived inflammatory group 2 innate lymphoid cells and lung-resident T cells and B cells. This network exacerbates the severity of allergic airway inflammation while hindering the systemic dissemination of pulmonary Mycobacterium tuberculosis. The identification of protozoan DNA sequences in the sputum of patients with severe allergic asthma further emphasizes the relevance of commensal protozoa in human disease. Collectively, these findings demonstrate that a commensal protozoan tunes pulmonary immunity via a gut-operated lung immune network, promoting both beneficial and detrimental disease outcomes in response to environmental airway allergens and pulmonary infections.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39706191/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39706191</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.020>10.1016/j.cell.2024.11.020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39706191</guid>
<pubDate>Fri, 20 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Kyle Burrows</dc:creator>
<dc:creator>Louis Ngai</dc:creator>
<dc:creator>Pailin Chiaranunt</dc:creator>
<dc:creator>Jacqueline Watt</dc:creator>
<dc:creator>Sarah Popple</dc:creator>
<dc:creator>Brian Forde</dc:creator>
<dc:creator>Saven Denha</dc:creator>
<dc:creator>Vitoria M Olyntho</dc:creator>
<dc:creator>Siu Ling Tai</dc:creator>
<dc:creator>Eric Yixiao Cao</dc:creator>
<dc:creator>Susana Tejeda-Garibay</dc:creator>
<dc:creator>Joshua F E Koenig</dc:creator>
<dc:creator>Katrin D Mayer-Barber</dc:creator>
<dc:creator>Catherine J Streutker</dc:creator>
<dc:creator>Katrina K Hoyer</dc:creator>
<dc:creator>Lisa C Osborne</dc:creator>
<dc:creator>Jun Liu</dc:creator>
<dc:creator>Liam O'Mahony</dc:creator>
<dc:creator>Arthur Mortha</dc:creator>
<dc:date>2024-12-20</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A gut commensal protozoan determines respiratory disease outcomes by shaping pulmonary immunity</dc:title>
<dc:identifier>pmid:39706191</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.020</dc:identifier>
</item>
<item>
<title>Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39706190/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>Psychiatric disorders are influenced by genetic and environmental factors. However, their study is hindered by limitations on precisely characterizing human behavior. New technologies such as wearable sensors show promise in surmounting these limitations in that they measure heterogeneous behavior in a quantitative and unbiased fashion. Here, we analyze wearable and genetic data from the Adolescent Brain Cognitive Development (ABCD) study. Leveraging >;250 wearable-derived features as digital...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 18:S0092-8674(24)01329-1. doi: 10.1016/j.cell.2024.11.012. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Psychiatric disorders are influenced by genetic and environmental factors. However, their study is hindered by limitations on precisely characterizing human behavior. New technologies such as wearable sensors show promise in surmounting these limitations in that they measure heterogeneous behavior in a quantitative and unbiased fashion. Here, we analyze wearable and genetic data from the Adolescent Brain Cognitive Development (ABCD) study. Leveraging >;250 wearable-derived features as digital phenotypes, we show that an interpretable AI framework can objectively classify adolescents with psychiatric disorders more accurately than previously possible. To relate digital phenotypes to the underlying genetics, we show how they can be employed in univariate and multivariate genome-wide association studies (GWASs). Doing so, we identify 16 significant genetic loci and 37 psychiatric-associated genes, including ELFN1 and ADORA3, demonstrating that continuous, wearable-derived features give greater detection power than traditional case-control GWASs. Overall, we show how wearable technology can help uncover new linkages between behavior and genetics.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39706190/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39706190</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.012>10.1016/j.cell.2024.11.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39706190</guid>
<pubDate>Fri, 20 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Jason J Liu</dc:creator>
<dc:creator>Beatrice Borsari</dc:creator>
<dc:creator>Yunyang Li</dc:creator>
<dc:creator>Susanna X Liu</dc:creator>
<dc:creator>Yuan Gao</dc:creator>
<dc:creator>Xin Xin</dc:creator>
<dc:creator>Shaoke Lou</dc:creator>
<dc:creator>Matthew Jensen</dc:creator>
<dc:creator>Diego Garrido-Martín</dc:creator>
<dc:creator>Terril L Verplaetse</dc:creator>
<dc:creator>Garrett Ash</dc:creator>
<dc:creator>Jing Zhang</dc:creator>
<dc:creator>Matthew J Girgenti</dc:creator>
<dc:creator>Walter Roberts</dc:creator>
<dc:creator>Mark Gerstein</dc:creator>
<dc:date>2024-12-20</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations</dc:title>
<dc:identifier>pmid:39706190</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.012</dc:identifier>
</item>
<item>
<title>Synthetic organizer cells guide development via spatial and biochemical instructions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39706189/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>In vitro development relies primarily on treating progenitor cells with media-borne morphogens and thus lacks native-like spatial information. Here, we engineer morphogen-secreting organizer cells programmed to self-assemble, via cell adhesion, around mouse embryonic stem (ES) cells in defined architectures. By inducing the morphogen WNT3A and its antagonist DKK1 from organizer cells, we generated diverse morphogen gradients, varying in range and steepness. These gradients were strongly...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Dec 11:S0092-8674(24)01323-0. doi: 10.1016/j.cell.2024.11.017. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In vitro development relies primarily on treating progenitor cells with media-borne morphogens and thus lacks native-like spatial information. Here, we engineer morphogen-secreting organizer cells programmed to self-assemble, via cell adhesion, around mouse embryonic stem (ES) cells in defined architectures. By inducing the morphogen WNT3A and its antagonist DKK1 from organizer cells, we generated diverse morphogen gradients, varying in range and steepness. These gradients were strongly correlated with morphogenetic outcomes: the range of minimum-maximum WNT activity determined the resulting range of anterior-to-posterior (A-P) axis cell lineages. Strikingly, shallow WNT activity gradients, despite showing truncated A-P lineages, yielded higher-resolution tissue morphologies, such as a beating, chambered cardiac-like structure associated with an endothelial network. Thus, synthetic organizer cells, which integrate spatial, temporal, and biochemical information, provide a powerful way to systematically and flexibly direct the development of ES or other progenitor cells in different directions within the morphogenetic landscape.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39706189/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39706189</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.017>10.1016/j.cell.2024.11.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39706189</guid>
<pubDate>Fri, 20 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Toshimichi Yamada</dc:creator>
<dc:creator>Coralie Trentesaux</dc:creator>
<dc:creator>Jonathan M Brunger</dc:creator>
<dc:creator>Yini Xiao</dc:creator>
<dc:creator>Adam J Stevens</dc:creator>
<dc:creator>Iain Martyn</dc:creator>
<dc:creator>Petr Kasparek</dc:creator>
<dc:creator>Neha P Shroff</dc:creator>
<dc:creator>Angelica Aguilar</dc:creator>
<dc:creator>Benoit G Bruneau</dc:creator>
<dc:creator>Dario Boffelli</dc:creator>
<dc:creator>Ophir D Klein</dc:creator>
<dc:creator>Wendell A Lim</dc:creator>
<dc:date>2024-12-20</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Synthetic organizer cells guide development via spatial and biochemical instructions</dc:title>
<dc:identifier>pmid:39706189</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.017</dc:identifier>
</item>
<item>
<title>Trustworthy implementation of artificial intelligence in cardiology: a roadmap of the European Society of Cardiology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39704781/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Dec 20:ehae748. doi: 10.1093/eurheartj/ehae748. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39704781/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39704781</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae748>10.1093/eurheartj/ehae748</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39704781</guid>
<pubDate>Fri, 20 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Folkert W Asselbergs</dc:creator>
<dc:creator>Thomas F Lüscher</dc:creator>
<dc:date>2024-12-20</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Trustworthy implementation of artificial intelligence in cardiology: a roadmap of the European Society of Cardiology</dc:title>
<dc:identifier>pmid:39704781</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae748</dc:identifier>
</item>
<item>
<title>Activation of Imprinted Gene &lt;em>;PW1&lt;/em>; Promotes Cardiac Fibrosis After Ischemic Injury</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39704066/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241225214156&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This study demonstrates that Pw1 imprinting is disrupted after injury and reveals a novel role for the downstream target PFAS in ECM production and cardiac fibrogenesis. Targeting the PW1/PFAS signaling pathway presents a promising therapeutic strategy for improving cardiac repair after injury.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 20. doi: 10.1161/CIRCULATIONAHA.124.070738. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Cardiac fibrosis, characterized by excessive extracellular matrix (ECM) deposition in the myocardium, is an important target for heart disease treatments. <i>Pw1</i> (paternally expressed gene 3) is an imprinted gene expressed from the paternal allele, and de novo purine biosynthesis (DNPB) is a crucial pathway for nucleotide synthesis. However, the roles of PW1 and DNPB in ECM production by cardiac fibroblasts during myocardial ischemia are not yet understood.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: To induce myocardial damage, we performed left anterior descending coronary artery ligation. We generated <i>Pw1</i><sup><i>CreER-2A-eGFP</i></sup> and <i>Pw1</i><sup><i>2A-CreER</i></sup> knock-in mouse lines to evaluate the expression of the 2 <i>Pw1</i> alleles in normal and injured hearts. Bisulfite sequencing was used to analyze the DNA methylation of the <i>Pw1</i> imprinting control region. We identified the phosphoribosylformylglycinamidine synthase (<i>Pfas</i>) gene, encoding the DNPB enzyme PFAS, as a direct target of PW1 using chromatin immunoprecipitation sequencing and real-time quantitative polymerase chain reaction. The role of DNPB in ECM production and cardiac fibrosis after injury was examined in vitro using cultured cardiac fibroblasts and in vivo with <i>Pfas</i>-deficient mice.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Our study demonstrates that myocardial infarction reduces DNA methylation at the imprinting control region of the maternally imprinted gene <i>Pw1</i>, triggering a switch from monoallelic imprinting to biallelic expression of <i>Pw1</i> in cardiac fibroblasts. In activated cardiac fibroblasts, increased <i>Pw1</i> expression promotes purine biosynthesis and induces ECM production by transcriptionally activating the DNPB factor <i>Pfas</i>. We identified that DNPB is essential for ECM production in activated fibroblasts and that loss of <i>Pfas</i> in fibroblasts limits cardiac fibrosis and improves heart function after injury.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study demonstrates that <i>Pw1</i> imprinting is disrupted after injury and reveals a novel role for the downstream target PFAS in ECM production and cardiac fibrogenesis. Targeting the PW1/PFAS signaling pathway presents a promising therapeutic strategy for improving cardiac repair after injury.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39704066/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241225214156&v=2.18.0.post9+e462414">39704066</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070738>10.1161/CIRCULATIONAHA.124.070738</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39704066</guid>
<pubDate>Fri, 20 Dec 2024 06:00:00 -0500</pubDate>
<dc:creator>Shan Kou</dc:creator>
<dc:creator>Zhengkai Lu</dc:creator>
<dc:creator>Defang Deng</dc:creator>
<dc:creator>Min Ye</dc:creator>
<dc:creator>Yu Sui</dc:creator>
<dc:creator>Lieyang Qin</dc:creator>
<dc:creator>Teng Feng</dc:creator>
<dc:creator>Zhen Jiang</dc:creator>
<dc:creator>Jufeng Meng</dc:creator>
<dc:creator>Chao-Po Lin</dc:creator>
<dc:creator>Xiajun Li</dc:creator>
<dc:creator>Chen Liu</dc:creator>
<dc:creator>Juan Tang</dc:creator>
<dc:creator>Hui Zhang</dc:creator>
<dc:date>2024-12-20</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Activation of Imprinted Gene &lt;em>;PW1&lt;/em>; Promotes Cardiac Fibrosis After Ischemic Injury</dc:title>
<dc:identifier>pmid:39704066</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070738</dc:identifier>
</item>





























</channel>
</rss>